Cysteamine hydrochloride, a transglutaminase2 inhibitor as therapeutic potential for oral submucous fibrosis
Background: Submucous fibrosis (SMF) was recognized as a definitive lesion by Schwartz who described it as a fibrosing condition in 1952 and due to its predilection for afflicting multiple sites in the oral cavity the disorder was listed as a “premalignant/precancerous condition”. Tissue transglutam...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Series: | Journal of Indian Academy of Oral Medicine and Radiology |
| Subjects: | |
| Online Access: | http://www.jiaomr.in/article.asp?issn=0972-1363;year=2023;volume=35;issue=1;spage=4;epage=9;aulast=Rajarathnam |